Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

Duopharma Biotech proposes 1-for-3 bonus

A blockchain advantage
Share on FacebookShare on Twitter

Duopharma Biotech Berhad has proposed a one-for-three bonus issue after posting a sterling first quarter ended Mar 31, 2021, with profit before tax climbing to RM23.18 million. This is more than 30 per cent from the RM17.73 million posted in the preceding year corresponding period.

This commendable achievement was made against quarterly revenue of RM166.45 million (2020: RM158.71 million), the company announced to Bursa Malaysia recently.

After accounting for taxation, net profit for the quarter was recorded at RM17.61 million (2020: RM13.56 million), translating to earnings per share (EPS) climbing to 2.49 sen for the quarter, from the 1.98 sen posted previously.

The 1-for-3 proposed bonus issue would entail the issuance of up to 239,926,896 new ordinary shares on an entitlement date to be determined and announced later, and subject to approvals from Bursa Securities, shareholders at a meeting of members to be convened and other relevant authorities.

In the same announcement, the Company also said that, on Feb 22, 2021, the Board of Directors had resolved that the Dividend Reinvestment Plan (“DRP”) approved by shareholders at the Company’s Extraordinary General Meeting on 31 May 2018 would apply to the second interim dividend of 6.0 sen per share amounting to approximately RM42.36 million.

The issue price of the new ordinary shares in the Company to be issued pursuant to the DRP has been fixed at RM3.08 per new Duopharma Biotech Berhad share. The issue price is at a discount of approximately 10 per cent to the 5-day ex-dividend volume weighted average market price (VWAMP) of RM3.42.

Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech

The entitlement date for the second interim dividend was on Apr 22, 2021, whilst the payment date was on May 21, 2021. The last day for submission of the Dividend Reinvestment Form was May 10, 2021.

Duopharma Biotech Group Managing Director Leonard Ariff Abdul Shatar attributed the stronger financial performance to improved revenue from higher sales to the consumer healthcare sector during the period.

Profit for the quarter also climbed as compared to the previous corresponding period mainly due to increase in sales during the quarter, coupled with forex losses posted in last year’s corresponding period.

Looking ahead, he expressed optimism that the Company would continue with its strong financial trajectory for the rest of 2021.

Tags: Duopharma BiotechLocal NewsThe Health June/JulytheHealth
Previous Post

NKF refutes viral postings

Next Post

Ronald McDonald House in Hospital Tunku Azizah

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Bridging healthcare access in Malaysia
    June 29, 2022
    There needs to be greater synergy between the various healthcare stakeholders […]
  • Am I losing my sight? My power keeps increasing
    October 6, 2021
    Myopia can progressively worsen to a higher power, so it is best to get your […]
  • Malaysian team in Cambridge study
    September 3, 2021
    DID you know that there are more than three billion alphabets in our genomes […]
  • Contact lens innovation
    January 3, 2023
    Johnson & Johnson Vision pioneers in meeting eye health needs with […]
  • Autoimmune diseases in kids
    September 3, 2021
    Two experts share four things scientists now know about autoimmune diseases in […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist